Related Experiment Videos
Nephron-sparing surgery for renal angiomyolipoma
Axel Heidenreich1, Axel Hegele, Zoltan Varga
1Department of Urology, Philipps University, Baldingerstrasse, 35043 Marburg, Germany. heidenre@post.med.uni-marburg.de
European Urology
|August 16, 2002
Summary
Nephron-sparing surgery (NSS) is effective for renal angiomyolipoma (RAML), showing no recurrences and preserving kidney function. This organ-preserving approach is feasible for RAML management.
Area of Science:
- Urology
- Oncology
- Nephrology
Background:
- Renal angiomyolipoma (RAML) is a benign kidney tumor that can grow and cause complications like hemorrhage.
- While organ preservation is ideal, data on nephron-sparing surgery (NSS) for RAML is limited.
Purpose of the Study:
- To evaluate the efficacy of NSS for RAML.
- Assessed renal function, tumor recurrence rates, and surgical feasibility.
Main Methods:
- Retrospective review of 28 patients with pathologically confirmed RAML who underwent NSS.
- Data collected included tumor size, symptoms, blood loss, and pre- and post-operative renal function.
- Follow-up data on tumor recurrence and long-term renal function were analyzed.
Main Results:
- No local tumor recurrences were observed in any patient during a median follow-up of 58 months.
- NSS was technically feasible with no intraoperative complications and minimal blood loss.
- Renal function remained stable post-operatively and at long-term follow-up, even in patients with a solitary kidney.
Conclusions:
- NSS is a highly successful and feasible surgical option for RAML when intervention is indicated.
- Long-term outcomes demonstrate no local recurrence and preserved renal function, supporting NSS as an organ-preserving strategy.